2012
DOI: 10.1016/j.placenta.2012.01.008
|View full text |Cite
|
Sign up to set email alerts
|

Placental drug transporters and their role in fetal protection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
85
0
9

Year Published

2014
2014
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 117 publications
(99 citation statements)
references
References 82 publications
3
85
0
9
Order By: Relevance
“…BCRP is highly expressed in the apical membrane of the syncytiotrophoblast [8, 48-50], and the up-regulation may promote increased efflux of BCRP substrates. Therefore, third-trimester chorioamnionitis has the potential to decrease accumulation of BCRP endogenous and exogenous substrates in the fetal compartment including folate, antibiotics and antiretrovirals.…”
Section: Discussionmentioning
confidence: 99%
“…BCRP is highly expressed in the apical membrane of the syncytiotrophoblast [8, 48-50], and the up-regulation may promote increased efflux of BCRP substrates. Therefore, third-trimester chorioamnionitis has the potential to decrease accumulation of BCRP endogenous and exogenous substrates in the fetal compartment including folate, antibiotics and antiretrovirals.…”
Section: Discussionmentioning
confidence: 99%
“…The fetal placenta consists of syncytiotrophoblast and cytotrophoblast layers. The BCRP is located in the maternalfacing apical membrane of the syncytiotrophoblast and the fetal blood vessels of the villous core, both of which are of fetal origin (Weier et al, 2008;Prouillac and Lecoeur, 2010;Mason et al, 2011;Ni and Mao, 2011;Iqbal et al, 2012;Staud et al, 2012). Therefore, only the genotypes of 421C > A and 34G > A polymorphisms in the ABCG2 gene of the children (but not mothers) might be associated with altered BCRP expression and transport activity in placenta, thereby modifying the inter-individual susceptibility to CHDs.…”
Section: Study Participantsmentioning
confidence: 99%
“…The placenta is obviously considered the crucial organ responsible for successful ontogeny. Evidence strongly suggests that the placenta expresses a range of transporters which are capable of controlling the transplacental dispositions of many toxicant agents, thereby playing a crucial role in fetal protection against maternal toxins (Myllynen et al, 2005Ceckova et al, 2006;Atkinson et al, 2007;Behravan and Piquette-Miller, 2007;Myren et al, 2007;Vahakangas and Myllynen, 2009;Prouillac and Lecoeur, 2010;Ni and Mao, 2011;Iqbal et al, 2012). Of main interest are the ATPbinding cassette (ABC) transporters, particularly the P-glycoprotein (P-gp) and the breast cancer resistance protein (BCRP), which are most intensively studied currently.…”
Section: Introductionmentioning
confidence: 99%
“…SSRIs administered during pregnancy will initially enter the maternal blood stream before passing through the placenta and into the blood stream of the fetus (Iqbal et al 2012). This transfer may cause an imbalance in fetal neurotransmission, which in turn may alter neural programming, plasticity, structural, and functional development (Gaspar et al 2003;).…”
Section: Introductionmentioning
confidence: 99%